Oncolytics Biotech, Inc. (ONCY)
0.964
-0.04
(-3.60%)
USD |
NASDAQ |
Feb 20, 16:00
0.985
+0.02
(+2.18%)
After-Hours: 20:00
Oncolytics Biotech SG&A Expense (Quarterly) : 4.593M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 26.18M |
| Edesa Biotech, Inc. | 1.217M |
| Lexaria Bioscience Corp. | 0.9023M |
| Xenon Pharmaceuticals, Inc. | 19.28M |
| ProMIS Neurosciences, Inc. | 1.953M |